Serono launches Novantrone web site
Submitted by art on Thu, 2004-01-22 07:42.
From their press release:
Serono, Inc., the marketer of Novantrone(R) (mitoxantrone for injection concentrate) in the United States for the Multiple Sclerosis (MS) indication, announces the launch of Novantrone.com, a valuable online resource for US-based patients with worsening MS, their caregivers, and healthcare professionals. This new web site provides access to comprehensive information about the disease, treatment with Novantrone(R), common questions, therapy considerations, as well as resources and tools to help patients and their physicians make important treatment and disease management decisions.
Check out the Novantrone FAQ here.